Proteins exert their effects
primarily by recognizing and binding to other molecules, a process that relies
on the compatibility of their shapes. This principle is illustrated by the
interaction between antibody proteins and antigens, as well as the binding of
morphine or heroin to opioid receptor proteins.
Proteins are structured at
three, and occasionally four, distinct levels. The primary structure consists
of a linear chain of amino acids. The secondary structure involves the folding or
coiling of this chain. The tertiary structure represents the overall
three-dimensional shape of a folded protein, while the quaternary structure occurs
when two or more peptide chains come together to form a larger protein complex.
For proteins to function biologically, they must be folded into these specific
three-dimensional shapes.
Beginning in the mid-1950s,
American biochemist Christian Anfinsen, working at the National Institutes of
Health, explored the relationship between protein structure and function. He
focused on ribonuclease, an enzyme responsible for breaking down ribonucleic
acid (RNA), due to its stability, small size, extensive study, and availability
in purified form. In 1957, Anfinsen discovered that when ribonuclease's
three-dimensional structure was disrupted, causing it to lose its biological
activity, it could spontaneously refold back into its native, fully functional
shape, thereby restoring its enzymatic activity. This behavior was observed in
many other proteins as well.
From these experiments,
Anfinsen concluded that the information necessary for a protein to achieve its
final three-dimensional conformation is encoded in its primary
structure—specifically, its amino acid sequence. He proposed the
"thermodynamic hypothesis," suggesting that ribonuclease adopts its
three-dimensional structure because it is the most stable configuration. In
recognition of his groundbreaking work linking amino acid sequences to the
biologically active shapes of proteins, Anfinsen was awarded the Nobel Prize in
Chemistry in 1972.
Several diseases, including
Alzheimer’s, Parkinson’s, and Huntington’s, have been linked to the
accumulation of misfolded proteins. These misfolded proteins are thought to
originate from amyloid proteins and are believed to increase with age,
potentially influenced by genetic factors.
No comments:
Post a Comment